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Abstract
Motivation: As cancer researchers have come to appreciate the importance of intratumor het-
erogeneity, much attention has focused on the challenges of accurately profiling heterogeneity
in individual patients. Experimental technologies for directly profiling genomes of single cells
are rapidly improving, but they are still impractical for large-scale sampling. Bulk genomic
assays remain the standard for population-scale studies, but conflate the influences of mixtures
of genetically distinct tumor, stromal, and infiltrating immune cells. Many computational ap-
proaches have been developed to deconvolute these mixed samples and reconstruct the genomics
of genetically homogeneous clonal subpopulations. All such methods, however, are limited to
reconstructing only coarse approximations to a few major subpopulations. In prior work, we
showed that one can improve deconvolution of genomic data by leveraging substructure in cel-
lular mixtures through a strategy called simplicial complex inference. This strategy, however,
is also limited by the difficulty of inferring mixture structure from sparse, noisy assays.
Results: We improve on past work by introducing enhancements to automate learning of sub-
structured genomic mixtures, with specific emphasis on genome-wide copy number variation
(CNV) data. We introduce methods for dimensionality estimation to better decompose mix-
ture model substructure; fuzzy clustering to better identify substructure in sparse, noisy data;
and automated model inference methods for other key model parameters. We show that these
improvements lead to more accurate inference of cell populations and mixture proportions in
simulated scenarios. We further demonstrate their effectiveness in identifying mixture substruc-
ture in real tumor CNV data.
Availability: Source code is available at
http://www.cs.cmu.edu/~ russells/software/WSCUnmix.zip
1 Introduction
Tumor heterogeneity is now recognized as a pervasive feature of cancer biology with implications for
every step of cancer development, progression, metastasis, and mortality. Most solid tumors exhibit
some form of hypermutability phenotype [15], leading to extensive genomic variability as tumor cell
populations expand [16]. Studies of single cells by fluorescence in situ hybridization (FISH) [27, 10]
have long revealed extensive cell-to-cell variability in single tumors, an observation that has since
been shown by single-cell sequencing technologies to occur with a far greater scale and variety of
mechanisms than previously suspected (e.g., [17, 14]). Furthermore, studies of clonal populations
across progression stages have revealed that it is often rare cell populations within this heterogeneity
that underlie progression, rather than the dominant clones [10]. Indeed, heterogeneity itself has
been shown to be predictive of progression and patient outcomes [7]. All of these observations have
suggested the importance of having ways of accurately profiling tumor heterogeneity, for both basic
cancer research and translational applications.
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Experimental technologies for profiling tumor heterogeneity are constantly improving, but are
so far impractical for systematically profiling variability genome-wide in large patient populations.
FISH and related imaging technologies are practical for profiling many thousands of cells, but only
at limited sets of preselected markers [10]. Single-cell sequencing can derive genome-wide profiles
of hundreds of cells in single tumors [33, 17], but is so far cost-prohibitive for doing so in more than
tiny patient populations. Furthermore, technical challenges make it difficult to develop accurate
profiles of structural variations, such as copy number variations (CNVs), which are the major
drivers of progression in most solid tumors [9]. Bulk regional sequencing can profile small numbers
of tumor sites per patient in large patient populations [32] but provides only a coarse picture of
the heterogeneity within each site.
These technical challenges to assessing heterogeneity experimentally have led to enormous in-
terest in computational deconvolution (also known as mixed membership modeling or unmixing)
methods as a way of computationally separating cell populations from mixed samples. Originally
proposed as a way of correcting for stromal contamination in genomic measurements [6], such
methods were later extended to reconstructing clonal substructure [21] and subclonal evolution [25]
among tumor cell populations. The past few years have seen an explosion of such methods for
deconvolution of numerous forms of genomic data sources (e.g., [24, 29, 19, 8, 13, 22]). All such
methods, however, are limited in accuracy and capable of resolving at best a few major clonal
subpopulations, a small fraction of the heterogeneity revealed by single-cell experimental studies.
These limits result from an inherent difficulty of separating high-dimensional mixtures, especially
from sparse, noisy data. The gap between the heterogeneity we know to be present and what we
can resolve by deconvolution is enormous, suggesting a need for further methodological advances.
In prior work, we proposed that one could better resolve genomic mixtures by taking account
of the fact that we would expect such mixtures to exhibit extensive substructure [22]. That is, an
individual tumor or tumor site is not likely to be a uniform mixture of all cell types observed across
all tumors in a study. Rather, one can expect distinct samples to group into subsets that share more
or fewer cells depending on how closely related they are to one another. All tumors can be expected
to share some contamination by normal cells while tumors with common subtypes can be expected
to share cell states characteristic of those subtypes. Likewise, tumor regions might be expected to
share more similarity with those nearby than with those more distant in the patient. This kind
of substructure is in principle exploitable to improve our ability to reconstruct accurate mixed
membership models. Specifically, by deconstructing tumor samples into subgroups with similar
mixtures, one can decompose the problem of reconstructing a high-dimensional mixture into the
easier problem of reconstructing several overlapping lower-dimensional mixtures. We previously
showed how to implement such an approach by adapting an earlier deconvolution strategy for
uniform mixtures that was based on identifying geometric structures (simplices) of tumor point
clouds in genomic space [25, 31]. We subdivide these point clouds into low-dimensional subsimplices
that collectively constitute a higher-level object known as a simplicial complex. This prior work
used a pipeline of several sequential steps to transform a genomic point cloud into a structured
mixed membership model [22]:
1. Pre-processing / filtration
2. Dimensionality reduction
3. Pre-clustering (partitioning) into uniform submixtures
4. Unmixing submixtures
5. Unifying mixtures into a structures simplicial complex model
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Figure 1: Overview of the full analysis pipeline: Input samples are represented by collections of
copy number (CN) call files, which are converted to a matrix format. These matrix inputs are
passed to our simplicial complex inference code, which infers a mixed membership model of the
data and associated model likelihood. The inference is computed by using principal components
analysis (PCA), following by pre-clustering, unmixing on each substructure (simplex), and using a
K-nearest-neighbor (KNN-based) reconciliation model. The inferred mixture components are then
used in downstream functional annotation to identify dysregulated pathways or term associations.
The resulting pipeline established a proof-of-concept for the approach, but also introduced several
difficult computational challenges. For example, it required accurately pre-specifying the number
of partitions and the dimensionality of each of the partitions, both difficult inference problems in
themselves that require significant knowledge of the system under study.
In the present work, we improve on this proof-of-concept method by tackling several subproblems
on the path to more completely automating inference of substructured genomic mixtures from
populations of tumor samples. We have eliminated several nuisance parameters from the prior work,
most notably by introducing methods for automated dimensionality estimation of subsimplicies and
automated maximum likelihood inference of other previously user-defined parameters. We have
further introduced a fuzzy clustering approach customized for simplicial complex decomposition to
better handle uncertainty in substructure decomposition. We verify the effectiveness of these new
methods on simulated data sets of known ground truth in comparison to our prior work and to a
more conventional Gaussian mixed membership model. We further demonstrate the practicality
of the new methods and their competitiveness with related work through a study of ovarian (OV)
tumor CNV data drawn from The Cancer Genome Atlas (TCGA) [34].
2 Methods
In this section, we go through each step of our improved analysis pipeline, followed by a discussion
of validation and application to simulated and real tumor data. We break the full inference problem
into a series of sequential steps. Figure 1 provides a high-level overview of the process. The following
subsections provide details on each component.
2.1 Input and Output Data
We conceptually model input data as a matrix M ∈ Rs×g, where the s ∈ N rows correspond to
distinct samples (which might be biopsies of tumors in a patient population, tumor sites in a patient,
or regions of a single tumor) and the g ∈ N columns correspond to probes along a genome (typically
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one per gene, although potentially at lower or higher resolution). For ease of exposition, we refer
to rows as tumors and columns as genes below. We use this generic matrix format because data
from many sources can be preprocessed into such a matrix (e.g., array-based data, whole-genome or
whole-exome sequencing data). We more specifically assume below that the input matrix contains
CNV data as might be derived from array comparative genomic hybridization (aCGH) or DNAseq
read depths. Although the strategy proposed here might be applied to other forms of genomic
measurement, CNV data would be expected to be more cleanly modeled as convex combinations of
pure cell types. Our goal is to decompose the rows of M into an approximately convex combination
of a smaller set of unknown mixture components (putative cell populations). More formally, we
seek a decomposition
M = FV +  (1)
where F ∈ Rs×k are mixture proportions, V ∈ Rk×g are unmixed subpopulations, k ∈ N is the
number of inferred cell subpopulations, and  ∈ Rs×g is an error matrix. F is interpreted as the
mixture fractions of the pure subpopulations, also called mixing proportions, and V as the inferred
genomic profiles of the pure subpopulations, also called mixture components. This interpretation
leads to natural constraints on the problem: 1)
∑
i Fij = 1 for a fixed j and 2) ∀i, j : 0 ≤ Fi,j ≤ 1.
Given these constraints, the formal goal of the method is to compute F and V given M , with an
intermediate step of determining the mixture dimension k.
2.2 Pre-processing
To begin analysis, we first pre-process M into a matrix of Z-scores:
Mz =
M − µM
σM
(2)
where µM is a vector of the mean copy numbers of each gene across all samples, and σM is a
vector of the standard deviations of the copy numbers. Next, to facilitate analysis of genomic point
clouds, we reduce the dimension of the data using principal components analysis (PCA) [20]. While
there are more sophisticated dimensionality reconstruction strategies available, we favor PCA as a
simple, standard method that has relatively modest data needs. We identify a total of kupper PCs,
using the Matlab pca routine in economy mode, where kupper ∈ N < g is an upper bound on the
number of cell subpopulations we will infer. In the present work, we use kupper = 7, intended to
be approximately an upper limit on the number of distinct mixture components a method of this
class might be able to infer. We denote the PCA scores, corresponding to amounts of each PC in
each tumor, as SM ∈ Rs×kupper . Lastly, we normalize the scores for each PC to a [0, 1] range, which
is then assumed by the pre-clustering technique applied in the next section [23]. We compute the
0-1 normalized version of SM as
S[0,1] =
SM −minSM
maxSM −minSM (3)
where the minimums and maximums are computed for each PC, taken over all samples.
2.3 Pre-clustering
We next pre-cluster data to identify initial candidate subsets of tumors inferred to draw from the
same set of mixture components. Each such subset will correspond to a distinct subsimplex of
the full simplicial complex to be inferred. While this is a clustering problem, it is a non-standard
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one in that we seek to cluster data into distinct low-dimensional subspaces of a contiguous higher-
dimensional point cloud, rather than into disjoint subclouds as is in conventional clustering. We
recently developed a specialized clustering method for this purpose [23], based on a two-stage
variant of medoidshift clustering [28]. We initially cluster in Euclidean PC space to reduce the raw
data to a smaller set of representative data points. We then cluster these representatives under a
negative-weight exponential kernel function using the ISOMAP distance measure [30], a form of
geodesic metric measuring distance between data points through a k-nearest-neighbor graph of the
input point cloud. The combination of ISOMAP distance and negative exponential kernel produces
a clustering in which cluster centroids are approximately extremal points of the simplicial complex
that serve to pull apart distinct subspaces of the point cloud. The initial Euclidean clustering
suppresses noise, which otherwise makes the negative exponential kernel highly sensitive to outlier
data. We refer the reader to [23] for full details. At the end of this process, we are left with a small
set of cluster representatives
M2stage = ∪iMN(xi), (4)
where each representative is itself a point in S[0,1], and a corresponding clustering of all tumors
C = {C1, . . . , Cr}, S[0,1] =
⋃
Ci∈C Ci.
We further assess uncertainty of the cluster assignments by determining a relative statistical
weight of each data point in each cluster. We use a weight function based on a folded multivariate
normal distribution, where the mean of the function is a 0 vector, the covariance matrix is the
identity multiplied by the distance from each cluster center to the mean of all cluster centers, and
the value at which the density function is evaluated is the distance from xi to Cj in ISOMAP space.
After these relative weights have been derived, we convert them to probabilities of assignment of
each point to each cluster. If we denote the raw weight of the ith data point as a vector Ri, then
we can define the normalized weight vector:
Wi =
Ri −minCj∈C Ri
maxCj∈C Ri −minCj∈C Ri
(5)
The clustering in principle depends on a chosen neighborhood size, although a scan over all possible
neighborhood sizes found no sensitivity of the final model likelihood to this parameter.
2.4 Dimensionality Inference
We next seek to estimate the dimension of each cluster, which will correspond to the number of
mixture components inferred for that cluster. The major challenge of this step is distinguishing a
genuine axis of variation from random noise, particularly when working with sparse, noisy genomic
measurements. Intuitively, we identify dimension by iteratively adding axes of variation via PCA
until we can no longer reject the hypothesis that variance in the next dimension is distinguishable
from noise.
We first build a model of expected noise per dimension by randomly sampling data points of
pure Gaussian noise with mean 0 and identity covariance. We then perform PCA on this random
point cloud and estimate the mean µG(i) and standard deviation σG(i) of the point cloud for each
PC i ∈ 1, ..., kupper. We then identify the smallest i ≤ kupper such that the standard deviation of the
true data in PC i is smaller than µG(i)+κσG(i), where κ defines a significance threshold in standard
deviations. In the present work, we set κ = 3 to yield effectively a significance threshold of < 0.01
for rejecting the hypothesis that the next dimension can be explained by Gaussian noise. The result
of this module, then, is a vector of inferred dimensions of each of the clusters: D ∈ {1, . . . , kupper}r.
We would expect this test to be conservative (underestimate true dimension), although less so as
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the size of the data set and its precision increases. We found it necessary to use a custom-made
conservative dimensionality estimator, as opposed to a more standard technique (e.g., [3]), because
the number of data points available in this application is much smaller than is typically assumed
by methods in this problem domain.
2.5 Cluster-wise Unmixing
We next seek to establish an initial mixed membership model by separately unmixing each cluster,
using the inferred dimension from the previous step as the number of mixture components. We
establish the model by minimizing an objective function based on the noise-tolerant geometric
unmixing method of [31]:
P (θ|X) ∝
r∏
i=1
(exp(−
s∑
j=1
(|xi − F ijV ij |W ij ))MST (Vj , Aj)γβ) (6)
where γ is a regularization penalty set based on an estimated signal-to-noise ratio (SNR) of the data
source [22], V are the inferred vertices, A is the adjacency matrix, MST is a minimum spanning tree
cost, W is the relative weight function computed above, F are the inferred mixture components, xi
is the ith data point, β is a BIC penalty for model complexity [26] and || is L1 distance. The first
term penalizes data points outside the bounding simplex via an exponentially-weighted L1 penalty.
The MST term captures a form of parsimony model on the simplex itself intended to penalize
the amount of mutation from a common source needed to explain the simplex vertices (mixture
components) [22]. We optimize for the objective function via the Matlab fmincon function, fitting
V and F to assign mixture components and mixture fractions to each cluster independently.
2.6 Reconciliation of Subsimplices into a Simplicial Complex
We next seek to join the discrete simplices, each modeling a subset of tumors as a uniform mixture,
into a unified simplicial complex. We accomplish this by merging simplex vertices if we cannot
reject the hypothesis that they represent distinct points in genomic space. We first establish a
probability model using the k-nearest-neighbors graph on tumors and vertices by modeling the set of
overlapping neighbors between two vertices via a hypergeometric distribution. On the assumption
two vertices draw their neighbor sets independently from the pool of all tumors, the expected
number of data points in common would be
|N1||N2|
N
(7)
where there are N data points, |N1| nearest neighbors of the first vertex, and |N2| neighbors of the
second vertex. We merge two vertices when the number of observed overlapping nearest neighbors is
above expectation. We empirically determined on our synthetic data that the method is insensitive
to the number of nearest neighbors for choices between 2 and
√
N and chose k = 15 nearest
neighbors arbitrarily within this range for the real data. This approach replaces computationally
costly bootstrap estimates used in our prior work [22].
2.7 Validation on Synthetic Data
To test our methods, we first sought to determine their effectiveness in reconstructing a series
of mixed membership models of known ground truth. For this purpose, we defined seven basic
simplicial complex structures of varying dimension and geometries, as in our prior work [22]. These
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Figure 2: The simplicial complex inference problem. (A) Illustration of a tumor phylogeny describ-
ing progression of a set of cell types, a realization of a population of tumors drawn from distinct
lineages in the phylogeny as a pair of low-dimensional subsimplices, and a model of the resulting
full simplicial complex as a union of simplices across lineages joined by their shared cell types.
(B) Illustration of seven scenarios of tumor phylogeny (left), each with a corresponding simplicial
structure (right), which are used to generate synthetic test cases for validation.
seven models are designed to encompass a wide variety of evolutionary scenarios and combinations
of subsimplex dimensions achieveable with a small number of mixture components. The simplicial
models and corresponding tumor evolution scenarios are illustrated in Fig. 2.
To simulate a tumor from a mixture scenario, we draw a set of vertices uniformly at random from
among the subsimplices. For each vertex, we sample a raw statistical weight uniformly at random
between 0 and 1 and normalize weights across vertices to yield a uniformly random mixture of
vertices. We further add Gaussian noise to each dimension, with standard deviation varied from
0 to 1.0 in units of 0.1. For each replicate of each model, we generate 250 tumors embedded in
50 dimensions, to yield a similar dataset after PCA to the 472 tumor samples in the real data we
examine. We perform replicates of the unmixing procedure for each scenario and noise level, varying
the number of nearest neighbors from 1 to
√
250. We also repeat the evaluation for neighborhood
sizes corresponding to each possible unique integer distance.
We apply our deconvolution method to each such data set and assess inference accuracy by the
root mean squared deviation (RMSD) of mixture components between real and inferred mixtures,
normalized by the product of the number of ambient dimensions and the number of ground truth
components. This measure evaluates the fractional error in the inferred genotypes of the unmixed
subpopulations. We compare this measure between our proposed method, an earlier version of
the method without fuzzy clustering, and three variants of Gaussian mixed membership modeling:
one also using our automated dimension estimates, one supplied with the true total dimension of
each data set, and another given only an upper bound on the dimensions. Unlike with our previous
approaches [25, 31, 22], there is no straightforward way to evaluate the mixture proportions derived
by the method in comparison to a ground truth, as the mixture fractions are re-weighted inside the
simplicial complex objective function.
2.8 Application to Real Tumor CNV Data
We next demonstrate the method on ovarian (OV) CNV data from the Cancer Genome Atlas
(TCGA)[34]. We downloaded level 3 CNV data for ovarian (OV) cancer, accessed on 15 July,
2015, consisting of 472 samples. We internally represent the data as maximal blocks of fixed copy
number along the genome, as in our previous work [23]. Although the blocks are potentially more
or less granular than genes, our method is agnostic to the granularity of data. From the inferred
geometric structure and the loading matrix from the principal components analysis, we obtain
chromosome coordinates for the CN data for significantly dysregulated regions of each inferred
subtype. We ran the full unmixing pipeline using the following parameters: maximum number
7
Table 1: Error in mixture estimation. Each column gives the mixture component inference error in
normalized RMSD between true components and the best-matching inferred component for each.
For the two methods using dimension estimation, GMM2 and SCwt., we also provide the difference
between the number of true and inferred components in parentheses. The columns correspond to
GMM with an upper bound on number of components (GMM1), GMM with automated dimension
estimation (GMM2), GMM given the true number of components (GMM3), unweighted simplicial
complex with an upper bound on components (SCunwt.), and simplicial complex with automated
dimension estimation (SCwt., i.e., the present method).
Scenario GMM1 GMM2 GMM3 SCunwt. SCwt.
1 0.0513 0.0133 (-3) 0.0267 0.0253 0.0188 (0)
2 0.0469 0.0133 (-3) 0.0243 0.0256 0.0185 (+8)
3 0.0534 0.0150 (-6) 0.0367 0.0267 0.0197 (-1)
4 0.0446 0.0150 (-5) 0.0319 0.0264 0.0197 (+6)
5 0.0482 0.0150 (-4) 0.0224 0.0263 0.0124 (+1)
6 0.0559 0.0143 (-4) 0.0262 0.0261 0.0160 (-1)
7 0.0590 0.0143 (-5) 0.0297 0.0256 0.0146 (-2)
of dimensions 7; number of bootstrapped replicates for pre-clustering 1000; neighborhood size
for pre-clustering 1; number of nearest neighbors for vertex merger 15; cutoff for dimensionality
estimation 3 standard deviations; maximum number of iterations of fmincon per simplex: 1000.
The choice of dimensionality reflects an approximate upper bound on the number of dimensions
methods of this class can infer, and some upper bounded is needed to limit runtime. The number
of bootstrap replicates was chosen empiricaly to be sufficiently large to ensure stable bootstrapped
clustering. The maximum number fmincon of iterations was also chosen empirically to be sufficient
to reach convergence. The neighborhood size of 1 corresponds well to assumptions made about the
medoidshift clustering procedure. For full details, see [23]. The number of nearest neighbors was
chosen based on tests on the simulated data showing the method to be insensitive to this parameter
up to approximately
√
N neighbors. The 3 standard deviations above the mean corresponds to a
p-value of 0.01. The runtime of the experiments depends largely upon the dimensionality of the
clusters (i.e., the number of subpopulations in the tumor dataset) and the number of iterations in
the minimization phase (iterations of fmincon).
3 Results
3.1 Validation on Synthetic Data
We assess the performance of the algorithm in comparison to a prior version of simplicial complex
unixing with medoid-shift clustering although without weighting and to a more generic Gaussian
mixture model (GMM). To test the value of the dimension estimation aspect of the present work
specifically, we compare to versions of the GMM fed the true dimension, an upper bound on the
dimension, or using dimension inferred by the same method as our simplicial complex approach.
Table 1 shows he results for each of the seven scenarios.
Comparing the two simplicial complex methods suggests that the novel methods introduced in
the present work do significantly improve accuracy relative to our prior strategy of upper-bounding
dimension in subsimplices. This is true even though the dimension estimates can be inaccurate,
with a tendency either to slightly underpredict or significantly overpredict the true dimension (mean
error +1.6). The GMM methods have mixed performance depending on the number of components
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Figure 3: Visualization of the Ovarian data (blue) and inferred components (black), with inferred
connections in black line. We can interpret the geometry in terms of a phylogeny of tumors, with
the two subsimplices, a tetrahedron and a triangle joined at an edge, corresponding to a putative
high-level split into two subtypes from a common normal ancestor (vertex 4) and a putative early
state of progression common to all subtypes (vertex 5). From there, two evolutionary trajectories
emerge, where one adds a leaf node at vertex 1, while the other contains vertices 2 and 3. This
phylogenetic intepretation can be derived from a minimum spanning tree among vertices as in [22],
with the edge lengths of this tree model providing one component of the model likelihood function.
inferred. Always using the upper-bound yields poor performance, which is improved by feeding
the method the true number of components. Suprisingly, GMM with inferred components yields
generally the lowest RMSDs despite generally significantly underestimating the dimension of the
data (mean error −4.3). This seemingly counterintuitive observation reflects an artifact of the
RMSD measure, in which one can get good RMSD scores by merging multiple true components into
a single inferred component, effectively fitting the components well but losing the desired mixture
structure. The approach of subdividing the problem into smaller, low-dimensional subproblems does
allow substantially better estimation of the qualitative simplicial structure, but more sophisticated
probabilistic models of these substructures may lead to better quality decompositions than our
current geometry-based unmixing approach.
3.2 Application to Ovarian Tumor CNV Data
To better illustrate the utility of the approach on real cancer data, we next applied it to a dataset
of CNV data from OV tumors taken from the TCGA [18]. Using parameters described in Section
2.8, the weighted unmixing procedure inferred a simplicial structure consisting of five vertices, with
substructures of a tetrahedron and a triangle conjoined at a line. The results are illustrated in
Fig. 3, which shows the true point cloud and inferred simplicial structure projected into PC space.
The figure shows two views, capturing the first three and next three PCs. The first view clearly
highlights a simplicial complex structure apparent in the raw data, consisting three arms branching
from a common point. The second view shows some of the variability in high dimensions, which
can be presumed to explain why a more complex mixture structure is inferred than seems apparent
in the first three PCs.
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To assess functional significance of inferred mixture components, we projected them from PC
back to genomic space and identified those CNV blocks with copy number above a Z-score of 2 in
each component at a resolution of 10 kb. We then identified genes overlapping these elevated blocks
using the UCSC Genome Browser [12, 11] to obtain a list of genes associated with the elevated
blocks. We identified statistically significant term associations for the resulting gene lists for each
mixture component using the DAVID toolkit [5]. Table 2 provides significant term associations
at p-value < 0.01 as clustered by DAVID. Most term associations were associated with vertices 1
and 5, with particular relevance for terms associated with chromatin structure. Vertex 2 which
distinguishes the triangular simplex from the tetrahedral, provided significant association to terms
associated with regulation by zinc finger transcription factors. Vertex 4, which we identify as an
inference of normal stromal cells, shows no term associations. There are also none found for vertex
3, which may indicate that it reflects only a minor axis of variation in these data. In addition to the
above pathway results, DAVID also found weakly significant (p < 0.05) tissue-specific expression
for the highlighted genes in multiple inferred vertices for uterine and ovarian carcinoma tissue, as
well as for lung tissue.
Direct comparison of the present method with other standard genomic deconvolution approaches
is challenging due to differing forms of input data required by all leading alternatives. Nonetheless,
we can compare our predictions to others performed on some of the same tumors for the purpose of
purity estimation [1]. Purity estimation is not the purpose of our method, but it can be considered
a subproblem of full mixture decomposition. To derive a comparable measure of tumor purity, we
identified vertex 4 of our simplicial complex model, for which no elevated regions of the genome
were detected, as the most plausible representative of genetically normal contaminating stromal
cells. We then estimated the purity of each tumor by a sum of its inferred fraction of non-normal
cells over subsimplices, weighted by its inferred probability of belonging to the given subsimplex
Our estimates compared to those of Aran et al. [1] have a Spearman correlation coefficient of 0.1436,
giving a weakly significant p-value of 0.0274 and showing that our decomposition is concordant with
prevailing purity estimates on a large set of real OV tumors. Table 3 provides a confusion matrix
comparing our method to THetA [19], a leading alternative method, in their concordance with the
TCGA purity estimation pipeline [1]. The Aran et al. consensus purity estimates are derived from
a combination of ABSOLUTE [2] (which uses genomic and karotyping information), annotation
based on immunological staining, and additional measures for which calls are unavailable to us.
Treating their consensus as our best estimate of a ground truth, we observe a weakly significant
correlation to our estimates although an insignificant anti-correlation to THetA. Since ABSOLUTE
and the staining are components of this consensus call, their high concordance is to be expected.
ABSOLUTE shows a significant correlation with the staining data, which neither our method nor
THetA shows. This may suggest the ABSOLUTE method is superior to our own at this task, but
could also reflect the fact that ABSOLUTE has direct karyotyping information as input, which
neither our method nor THetA does, or the fact that ABSOLUTE is designed for purity estimation
while neither our method nor THetA are. We thus hesitate to draw strong conclusions from these
data given the wide differences in goals and input data types between methods, but nonetheless
suggest they do show that our method is at least competitive with a popular alternative genomic
deconvolution method at the task of separating tumor and non-tumor subpopulations.
4 Conclusions
We have developed novel strategies for taking better advantage of mixture substructure in decon-
volution of mixed genomic data from heterogeneous tumor samples. This contribution is intended
to advance a theoretical method for better taking advantage of substructure in complex genomic
10
Table 2: DAVID results for enriched term associations of OV simplicial complex vertices. Each row
identifies the relevant vertex, term association, DAVID cluster of the term, and p-value. ∗: terms
condensed, reporting highest corrected p-value.
Vertex Term Cluster p-value
1 GO:nucleosome* 1 ≤ 1.53× 10−29
1 GO:protein-DNA complex* 1 ≤ 8.48× 10−30
1 GO:Chromatin* 1 ≤ 6.81× 10−10
1 GO:DNA Packing/Binding 1 ≤ 2.76× 10−13
1 KEGG:lupis erythematosis 1 2.31× 10−19
1 Pather:Histone 1 1.17× 10−18
1 Reactome:Telomere Maint. 1 1.08× 10−18
1 GO:Cellular Macromolecular component org.* 1 9.20× 10−4
5 GO:nucleosome* 1 ≤ 1.53× 10−29
5 GO:protein-DNA complex* 1 ≤ 8.48× 10−30
5 GO:Chromatin* 1 ≤ 6.81× 10−10
5 GO:DNA Packing/Binding 1 2.76× 10−13
5 KEGG:lupis erythematosis 1 2.31× 10−19
5 Panther:Histone 1 1.17× 10−18
5 Reactome:Telomere Maint. 1 1.08× 10−18
5 GO:Cellular Macromolecular component org.* 1 9.20× 10−4
1 GO:DNA Binding* 2 ≤ 3.19× 10−3
2 Panther:KRAB box TF 2 6.96× 10−7
2 Panther:ZF TF 2 8.63× 10−4
5 GO:DNA Binding* 2 ≤ 3.19× 10−3
1 Panther: Lactation, mammary development 3 3.63× 10−7
5 Panther:Lactation, mammary development 3 3.63× 10−7
1 GO/KEGG: Olfactory* 4/5 ≤ 5.29× 10−3
5 GO/KEGG: Olfactory* 4/5 ≤ 5.29× 10−3
1 Panther:MHCI-mediated immunity 6 6.63× 10−3
5 Panther:MHCI-mediated immunity 6 6.63× 10−3
1 Panther:KRAB box TF 7 1.24× 10−3
5 Panther:KRAB box TF 7 1.24× 10−3
5 GO/Panther: Phosphate* 8 ≤ 5.49× 10−3
mixtures, an approach that might be incorporated into many existing approaches for cell type de-
convolution using assorted data types or inference models. The advances in the present paper bring
us closer to the goal of deriving precise models of mixture substructure in the face of sparse, noisy
genomic data without the need for extensive expert intervention. For this purpose, we have intro-
duced new strategies for automated inference of subcluster dimensions, automated construction of
a global simplicial complex structure, and better deconvolution of submixtures on small samples
with uncertain subclustering. We have shown that we can automatically learn model structure from
realistic sizes of data set without degrading performance of the model relative to methods requiring
significantly more user intervention. While we focus specifically on deconvolution of CNV data,
we believe that this simplicial complex approach for substructured mixture decomposition could
be adopted for a variety of genomic data types (CNV, SNV, RNA, methylation) and technologies
(array, sequence).
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Table 3: Confusion matrix of correlations between purity estimates on TCGA OV data for WSC
(our method), THetA, ABSOLUTE, expert annotation from immunological staining, and a con-
sensus call derived from ABSOLUTE, staining, and additional estimators for which calls are un-
available. Each entry presents the correlation coefficient between shared samples OV followed by
statistical significance in parentheses.
WSC THetA ABSOLUTE Staining Consensus
WSC 1 (0) -0.11 (0.11) 0.035 (0.60) -0.035 (0.59) 0.14 (0.027)
THetA -0.11 (0.11) 1 (0) -0.041 (0.68) -0.13 (0.086) 0.034 (0.79)
ABSOLUTE 0.035 (0.60) -0.041 (0.68) 1 (0) 0.32 (2.2e-14) 0.85 (1.9e-152)
Staining -0.035 (0.59) -0.13 (0.086) 0.32 (2.2e-14) 1 (0) 0.27 (4.2e-11)
Consensus 0.14 (0.027) -0.030 (0.70) 0.85 (1.9e-152) 0.27 (4.2e-11) 1 (0)
This ultimate goal of the present work is to make sophisticated mixture deconvolution ap-
proaches more widely accessible to a non-expert community, by allowing them to be incorporated
more broadly into a variety of deconvolution approaches in the literature. Much work still remains,
though, both in better automating approaches and improving inference quality. There are still
several (hyper-)parameters for which the task of automated learning remains challenging. While
automated dimension estimation appears valuable in improving simplicial complex models, deriv-
ing accurate estimates is a significant challenge for noisy data [4]. Integration of multiple forms of
genomic data into a common mixture framework is likewise a promising but challenging direction
for improving inference quality. In particular, as single-cell methods become more cost-effective,
combinations of bulk and single-cell data may prove particularly informative. Finally, the simpli-
cial complex models themselves require refinement to better capture the real sources of genomic
mixture substructure they are meant to model, including substructure imposed by common path-
ways of subtype evolution, spatial constraints in the tumor microenvironment, and other sources
of mixture substructure that do not conform well to our current simplicial complex model.
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